|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
14,240,000 |
Market
Cap: |
99.68(M) |
Last
Volume: |
231,508 |
Avg
Vol: |
230,868 |
52
Week Range: |
$4.06 - $8.25 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 2.7 |
Insider 6 Months : 8.4 |
Insider 3/6 Months : 11.5 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lifevantage engages in the identification, research, development, formulation and sale of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and other products. Co.'s line of dietary supplements includes its primary Protandim® family of products, LifeVantage® Omega+, ProBio, IC Bright®, and Daily Wellness dietary supplements. TrueScience® is Co.'s line of skin, hair, bath and body, and other products. Co. also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio®, its nootropic energy drink mixes, and PhysIQ, its weight management system.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
449 |
19,932 |
66,560 |
72,210 |
Total Buy Value |
$3,142 |
$96,554 |
$335,842 |
$358,711 |
Total People Bought |
1 |
2 |
5 |
5 |
Total Buy Transactions |
1 |
7 |
16 |
20 |
Total Shares Sold |
0 |
5,500 |
5,500 |
5,500 |
Total Sell Value |
$0 |
$33,000 |
$33,000 |
$33,000 |
Total People Sold |
0 |
1 |
1 |
1 |
Total Sell Transactions |
0 |
1 |
1 |
1 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Beindorff Michael A |
Director |
|
2020-11-12 |
4 |
A |
$11.15 |
$75,753 |
D/D |
6,794 |
73,281 |
|
- |
|
Lewis Darwin |
Director |
|
2020-11-12 |
4 |
A |
$11.15 |
$75,753 |
D/D |
6,794 |
53,873 |
|
- |
|
Wach Charles J. |
Chief Operating Officer |
|
2020-10-01 |
4 |
D |
$11.85 |
$8,911 |
D/D |
(752) |
36,000 |
|
- |
|
Wach Charles J. |
Chief Operating Officer |
|
2020-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
981 |
36,737 |
|
- |
|
Fife Steven R |
CFO and Interim CEO |
|
2020-10-01 |
4 |
D |
$11.85 |
$19,837 |
D/D |
(1,674) |
153,217 |
|
- |
|
Fife Steven R |
CFO and Interim CEO |
|
2020-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,770 |
154,891 |
|
- |
|
Mcmurray Kevin |
General Counsel |
|
2020-10-01 |
4 |
D |
$11.85 |
$7,963 |
D/D |
(672) |
49,824 |
|
- |
|
Mcmurray Kevin |
General Counsel |
|
2020-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
981 |
50,496 |
|
- |
|
Rose Justin |
Chief Sales &Marketing Officer |
|
2020-10-01 |
4 |
D |
$11.85 |
$10,238 |
D/D |
(864) |
153,709 |
|
- |
|
Rose Justin |
Chief Sales &Marketing Officer |
|
2020-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,178 |
153,603 |
|
- |
|
Mcmurray Kevin |
General Counsel |
|
2020-09-26 |
4 |
D |
$12.42 |
$52,537 |
D/D |
(4,230) |
49,515 |
|
- |
|
Rose Justin |
Chief Sales &Marketing Officer |
|
2020-09-16 |
4 |
AS |
$13.58 |
$16,975 |
D/D |
(1,250) |
152,425 |
|
-31% |
|
Fife Steven R |
CFO and Interim CEO |
|
2020-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
152,121 |
|
- |
|
Rose Justin |
Chief Sales Officer |
|
2020-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
16,880 |
153,675 |
|
- |
|
Wach Charles J. |
Chief Operating Officer |
|
2020-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,376 |
35,756 |
|
- |
|
Fife Steven R |
Chief Financial Officer |
|
2020-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
15,637 |
122,121 |
|
- |
|
Goodwin Ryan |
Chief Marketing Officer |
|
2020-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,732 |
149,343 |
|
- |
|
Rose Justin |
Chief Sales Officer |
|
2020-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,673 |
136,795 |
|
- |
|
Mcmurray Kevin |
General Counsel |
|
2020-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,320 |
53,745 |
|
- |
|
Wach Charles J. |
Chief Operating Officer |
|
2020-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,320 |
32,380 |
|
- |
|
Jensen Darren Jay |
Chief Executive Officer |
|
2020-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,303 |
459,590 |
|
- |
|
Jensen Darren Jay |
Chief Executive Officer |
|
2020-08-19 |
4 |
AS |
$13.13 |
$59,085 |
D/D |
(4,500) |
449,287 |
|
-34% |
|
Rose Justin |
Chief Sales Officer |
|
2020-08-19 |
4 |
AS |
$13.26 |
$16,575 |
D/D |
(1,250) |
132,122 |
|
-34% |
|
Jensen Darren Jay |
Chief Executive Officer |
|
2020-08-09 |
4 |
D |
$13.56 |
$248,840 |
D/D |
(18,351) |
453,787 |
|
- |
|
Rose Justin |
Chief Sales Officer |
|
2020-07-15 |
4 |
AS |
$13.55 |
$16,938 |
D/D |
(1,250) |
133,372 |
|
-19% |
|
393 Records found
|
|
Page 8 of 16 |
|
|